Jeffrey M. Jonas
2021
Compensation breakdown
| Non-Equity Incentive Plan | $280,547 |
|---|---|
| Option Awards | $1,825,102 |
| Salary | $625,000 |
| Stock Awards | $1,398,590 |
| Other | $17,463 |
| Total | $4,146,702 |
Jonas received $1.8M in option awards, accounting for 44% of the total pay in 2021.
Jonas also received $280.5K in non-equity incentive plan, $625K in salary, $1.4M in stock awards and $17.5K in other compensation.
Rankings
In 2021, Jeffrey M. Jonas' compensation ranked 3,226th out of 12,397 executives tracked by ExecPay. In other words, Jonas earned more than 74.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,226 out of 12,397 | 74th |
Division Manufacturing | 1,310 out of 5,492 | 76th |
Major group Chemicals And Allied Products | 531 out of 2,367 | 78th |
Industry group Drugs | 471 out of 2,090 | 78th |
Industry Pharmaceutical Preparations | 324 out of 1,537 | 79th |
Pay ratio
| Jeffrey M. Jonas' Pay | $4,146,702 |
|---|---|
| Median Employee's Pay | $308,210 |
| Pay Ratio | 13to 1 |
In 2021, the annual total compensation of Jeffrey M. Jonas was $4,146,702.
The annual total compensation of the median employee at Sage Therapeutics was $308,210.
The ratio of Jeffrey M. Jonas' pay to the pay of median employee was therefore 13 to one.
Jonas' colleagues
We found four more compensation records of executives who worked with Jeffrey M. Jonas at Sage Therapeutics in 2021.
News
April 28, 2022
April 29, 2021
April 29, 2020
April 25, 2019